Home' Australian Pharmacist : Australian Pharmacist September 2016 Contents Australian Pharmacist September 2016 I © Pharmaceutical Society of Australia Ltd.
» LEGAL GEMS
BY DENISE L HOPE1*
, STEVEN T DICKFOS2
, MICHELLE A KING3
Optometrists with general registration may use particular scheduled
medicines for diagnostic purposes.
1(App. B) Optometrists endorsed for
scheduled medicines with the Optometry Board of Australia (OBA)
may prescribe from a specified list of S2, S3 and S4 medicines in the
therapeutic management of eye conditions.
Additionally, endorsed optometrists may
become eligible to write prescriptions
for certain PBS listed medicines, which
include some of the OBA approved
medicines and many unscheduled
ocular lubricant preparations.2 However,
not all optometrical items on the PBS are
on the approved OBA list.
Endorsed optometrists need to prescribe
within the legislative framework of their
jurisdiction of practice. All states and
territories confer optometrist prescribing
rights in primary medicines legislation
except South Australia and the ACT.
In South Australia, it is stated3 that
non-medical prescribing is governed
by particular legislation4 yet neither
this, nor the medicines legislation5,6
specifically authorises optometrist
prescribing. Under ACT medicines
legislation optometrists can obtain,
possess, administer and issue purchase
orders or requisitions for S2, S3 and
S4 medicines, but not prescribe,
Part 1.8) and ancillary documentation
must be consulted to confirm the
prescribing requirements for endorsed
optometrists.8 Key prescribing
requirements for Endorsed
1. Optometry Board of Australia. Guidelines for Use of
Scheduled Medicines. 2014. AT: www.optometryboard.gov.
au/Policies-Codes-Guidelines.aspx. Accessed 13 Jun 2016.
2. Australian Government Department of Health.
Optometrist PBS Prescribing. 2016. AT: https://www.pbs.
gov.au/browse/optometrical. Accessed 13 Jun 2016.
3. Government of South Australia: SA Health.
Prescribing by non-medical healthcare professionals.
2016. At: www.sahealth.sa.gov.au/wps/wcm/
medical+professionals. Accessed 13 Jun 2016.
4. Government of South Australia. Health Practitioner
Regulation National Law (South Australia) Act 2010. 2014.
At: https://www.legislation.sa .gov.au/LZ/C/A/Health%20
(South%20Australia)%20Act%202010.aspx. Accessed 13
5. Government of South Australia. Controlled Substances
Act 1984. 2016. At: www.legislation.sa.gov.au/LZ/C/A/
Accessed 8 Jun 2016.
6. Government of South Australia. Controlled Substances
(Poisons) Regulations 2011. 2016. At: www.legislation.sa .gov.
Regulations%202011.aspx. Accessed 13 Jun 2016.
7. Australian Capital Territory Government. Medicines,
Poisons and Therapeutic Goods Regulation 2008. 2016. At:
42.pdf. Accessed 13 Jun 2016.
8. Australian Capital Territory Government. Key prescribing
requirements for Endorsed Optometrists. 2015. At: www.
optometrists.pdf. Accessed 13 Jun 2016.
1. Denise L Hope, BPharm, MMedRes,
GradCertHigherEd; Lecturer, School of Pharmacy,
Griffith University, Queensland, Australia.
2. Steven T Dickfos, BSc (Oceanography),
BPharmaceutSci, MPharm; Flight Lieutenant, Royal
Australian Air Force (RAAF), Canberra, Australia.
3. Michelle A King, BPharm, PhD (Med); Senior Lecturer,
Menzies Health Institute Queensland and School of
Pharmacy, Griffith University, Queensland, Australia.
*Corresponding author: email@example.com
TWG and Chemmart
The Terry White Group and Chemmart
pharmacy groups will merge to form one of
Australia’s largest retail pharmacy networks.
The merged group will have a combined
retail turnover of $2 billion and
approximately 500 pharmacies.
EBOS Group Limited will sell the business
assets of Chemmart to Terry White Group
in exchange for equity and will invest
additional capital to achieve a 50% equity
stake in the merged entity. The proposed
merger is subject to Terry White Group
shareholder approval and will be put to a
vote at an Extraordinary General Meeting
in late September.
Terry White Group CEO Anthony White
said both networks had complementary
retail offerings, strong cultural synergies
and a mutual focus on value for money
and front line health services that would
deliver a stronger, more capable network
‘ The merger of the two networks creates
a comprehensive national footprint and
increased scale which, when combined
with capabilities across retail, merchandise
and private label, will improve the group’s
competitiveness and front line health
service delivery for the benefit of all
our pharmacy owners and customers,’
Mr White said.
EBOS Group CEO Patrick Davies said the
merger would provide both immediate
and long term benefits through building
the strongest retail pharmacy network in
Australia, underpinned by a substantial
and sophisticated retail pharmacy model.
‘Chemmart and Terry White Group
have strong, vibrant brands that have
high levels of customer awareness and
established leadership positions within
the market,’ Mr Davies said.
‘ This merger is about capitalising on those
strengths and continuing to develop a
competitive and sustainable offering for
all pharmacy owners in the group while
also significantly increasing our ability to
meet the evolving needs of our customers.’
Links Archive Australian Pharmacist August 2016 Australian Pharmacist October 2016 Navigation Previous Page Next Page